Re: Upcoming Zenith Events
|
2
|
Zenith Epigenetics
|
Feb 27, 2019 10:50PM
|
Re: New Zack's Report
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 12, 2021 10:15AM
|
Re: BIO-Europe Presentation is up
|
2
|
Resverlogix Corp.
|
Nov 07, 2017 01:04PM
|
Re: Big pharma ...
|
2
|
Resverlogix Corp.
|
Apr 05, 2017 08:45PM
|
Re: anyone thinking halt for NR before presentation tomorrow?
|
2
|
Resverlogix Corp.
|
Oct 13, 2016 09:23AM
|
Re: DM Clip from B&B
|
2
|
Resverlogix Corp.
|
May 19, 2018 11:08AM
|
Re: Trying to understand placebo rste of MACE
|
2
|
Resverlogix Corp.
|
Feb 23, 2019 10:22AM
|
Re: ERA-EDTA 2019 June 13-16
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 09:14AM
|
Re: 2019 Potential Events
|
2
|
Resverlogix Corp.
|
Jun 24, 2019 02:15PM
|
Resverlogix Announces TSX Review Update
|
2
|
Resverlogix Corp.
|
Apr 12, 2018 08:49AM
|
Re: Poster
|
2
|
Zenith Epigenetics
|
Jun 16, 2020 07:25AM
|
Re: Roth research report
|
2
|
Resverlogix Corp.
|
Nov 01, 2018 04:17PM
|
Re: BETonMACE ClinicalTrial.gov updated
|
2
|
Resverlogix Corp.
|
Sep 29, 2017 09:50AM
|
Re: Motley Fool - Resverlogix one of three biotechs than can "Electrify your TFSA"
|
2
|
Resverlogix Corp.
|
Jun 24, 2018 12:00PM
|
Re: Zenith and Breast Cancer
|
2
|
Zenith Epigenetics
|
Mar 11, 2018 10:47AM
|
Re: ZENITH CALL
|
2
|
Zenith Epigenetics
|
Jun 20, 2016 01:52PM
|
Re: Final Short Term Prospectus and other Related Documents now on SEDAR
|
2
|
Resverlogix Corp.
|
Jun 04, 2019 02:29PM
|
Re: Resverlogix Announces Key BETonMACE Renal Data from Plenary Session Presentation at ERA-EDTA Virtual Congress
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 09:27AM
|
4 Events in the Next 4 to 6 Weeks
|
2
|
Resverlogix Corp.
|
Feb 16, 2019 11:54AM
|
Re: Article: Could Inflammation be the cause of myriad chronic conditions?
|
2
|
Resverlogix Corp.
|
Apr 28, 2019 10:21PM
|